Tag: ADPribose

Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome

This article was originally published here Comput Struct Biotechnol J. 2021 Aug 10;19:4435-4446. doi: 10.1016/j.csbj.2021.08.007. eCollection 2021. ABSTRACT Poly (ADPribose) polymerase inhibitors (PARPis) are clinically approved drugs designed according to the concept of synthetic lethality (SL) interaction. It is crucial to expand the scale of patients who can benefit from…

Continue Reading Revealing biomarkers associated with PARP inhibitors based on genetic interactions in cancer genome